Clinical Trial

Fluid Responsiveness and Venous Congestion Evolution During Volume Expansion

Study acronym: FREVO
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 13, 2025 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Fluid responsiveness is a critical determinant guiding fluid therapy in critically ill patients. However, excessive fluid administration can result in fluid overload, leading to venous congestion and worse clinical outcomes. Venous congestion, a marker of impaired fluid clearance, is increasingly recognized as a significant contributor to poor prognosis. Previous studies have demonstrated the coexistence of fluid responsiveness and venous congestion in critically ill patients. Notably, these studies were limited by the absence of fluid challenge-the gold standard for assessing fluid responsiveness-leaving the dynamic relationship between fluid responsiveness and venous congestion incompletely understood. This study aims to investigate the interplay and temporal evolution of fluid responsiveness and venous congestion following a standardized fluid challenge in critically ill patients.
Trial Details
NCT Number NCT06772038
Lead Sponsor Bicetre Hospital
Collaborators: First Affiliated Hospital, Sun Yat-Sen University, Longgang District People's Hospital of Shenzhen
Conditions Hemodynamic, Fluid Responsiveness, Venous Congestion, Fluid Challenge
Enrollment 64 participants
Start Date 2025-01-05
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-07-30 (estimated)
Updated on ClinicalTrials.gov 2025-01-13